Meejeon Roh

Understanding prostate cancer using molecular biology approaches in combination with transgenic mouse model has been the main focus of my independent and collaborative research. I have an extensive expertise in mouse models as well as molecular characteristics of cancer cells. My ultimate research goal is to translate what we have learned in the laboratory setting into clinically relevant therapy, which is evidenced by my grant supports oriented to translational research. Recently, I have been working with Dr. Schaeffer to understand the molecular alterations behind the racial disparity of African American men in prostate cancer, specifically the role of VGLL3, a newly identified novel racial disparity modulator in prostate cancer. Our focus is to investigate its role and underlying molecular mechanism as well as its value as a biomarker in prostate cancer using various cancer cell models. I am well-qualified to perform this proposal based on extensive molecular biology and translational research experience and collaboration expertise.